rs387906299
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PM4_SupportingPP3PP5_Very_Strong
The NM_020247.5(COQ8A):c.1750_1752del(p.Thr584del) variant causes a inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000791 in 1,605,520 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. S582S) has been classified as Likely benign.
Frequency
Consequence
NM_020247.5 inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
COQ8A | NM_020247.5 | c.1750_1752del | p.Thr584del | inframe_deletion | 15/15 | ENST00000366777.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
COQ8A | ENST00000366777.4 | c.1750_1752del | p.Thr584del | inframe_deletion | 15/15 | 1 | NM_020247.5 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000974 AC: 14AN: 143788Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000123 AC: 31AN: 251330Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135854
GnomAD4 exome AF: 0.0000773 AC: 113AN: 1461732Hom.: 0 AF XY: 0.0000798 AC XY: 58AN XY: 727172
GnomAD4 genome ? AF: 0.0000974 AC: 14AN: 143788Hom.: 0 Cov.: 32 AF XY: 0.0000712 AC XY: 5AN XY: 70226
ClinVar
Submissions by phenotype
Autosomal recessive ataxia due to ubiquinone deficiency Pathogenic:4Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Centogene AG - the Rare Disease Company | Feb 18, 2021 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 2008 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 31, 2016 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Dec 17, 2021 | - - |
not provided Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 18, 2021 | The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant has been identified in at least one individual with clinical features associated with this gene. Assessment of experimental evidence suggests this variant may result in abnormal protein function. Studies showed this variant exhibited reduced protein function by failing to restore growth on selective respiratory medium (PMID: 18319074). This variant appears to segregate with disease in at least one family. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 08, 2015 | The c.1750_1752delACC mutation in the ADCK3 gene has been reported previously in combination with a second disease-causing mutation in an individual with Coenzyme Q10 deficiency and cerebellar ataxia (Lagier-Tourenne et al., 2008). Studies in a fibroblast cell line from this patient as well as in yeast with the c.1750_1752delACC mutation show that this mutation impacts the function of the protein (Lagier-Tourenne et al., 2008). The c.1750_1752delACC mutation causes an in-frame deletion of a Threonine residue at codon 584, denoted p.Thr584del. The c.1750_1752delACC mutation was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The presence of this variant is consistent with ataxia, gait imbalance, tremor and slowly progressive cerebellar volume loss. We interpret c.1750_1752delACC as a disease-causing mutation. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Invitae | Jan 18, 2024 | This variant, c.1750_1752del, results in the deletion of 1 amino acid(s) of the COQ8A protein (p.Thr584del), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has been observed in individual(s) with CoQ10 deficiency (PMID: 18319074, 27572814, 29915382, 30637285). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 3644). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects COQ8A function (PMID: 18319074, 26866375). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at